<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://www.dombey.capital/market/why-applied-digital-stock-rose</loc><news:news><news:publication><news:name>Dombey Capital</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-19T11:52:00-04:00</news:publication_date><news:title>Applied Digital (APLD) Stock: Why It Rose 11% on Insider Buying</news:title></news:news></url>
  <url><loc>https://www.dombey.capital/market/why-arcutis-stock-rose</loc><news:news><news:publication><news:name>Dombey Capital</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-19T16:55:00-04:00</news:publication_date><news:title>Arcutis (ARQT) Stock: Why It Rose 11% on a Guggenheim Target Raise</news:title></news:news></url>
  <url><loc>https://www.dombey.capital/market/why-cleveland-cliffs-stock-rose</loc><news:news><news:publication><news:name>Dombey Capital</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-19T11:30:00-04:00</news:publication_date><news:title>Cleveland-Cliffs (CLF) Stock: Why It Jumped 15% After Earnings</news:title></news:news></url>
  <url><loc>https://www.dombey.capital/market/why-disc-medicine-stock-rose</loc><news:news><news:publication><news:name>Dombey Capital</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-19T11:40:00-04:00</news:publication_date><news:title>Disc Medicine (IRON) Stock: Why It Jumped 37% on Phase 3 Data</news:title></news:news></url>
  <url><loc>https://www.dombey.capital/market/why-parabilis-stock-rose</loc><news:news><news:publication><news:name>Dombey Capital</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-19T17:30:00-04:00</news:publication_date><news:title>Parabilis Medicines (PBLS) Stock: Why It Rose 11% Before ESMO</news:title></news:news></url>
  <url><loc>https://www.dombey.capital/market/why-veradermics-stock-rose</loc><news:news><news:publication><news:name>Dombey Capital</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-19T17:00:00-04:00</news:publication_date><news:title>Veradermics (MANE) Stock: Why It Rose 12% on Phase 3 Hair Data</news:title></news:news></url>
</urlset>
